5-hydroxymethylcytosine profiling as an indicator of cellular state

Epigenomics

Volumn 5, Issue 6, 2013, Pages 655-669

  Laird, Alexander ^a,b   Thomson, John P ^a   Harrison, David J ^b,c   Meehan, Richard R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

cancer; cellular state; epigenetics; hydroxymethylcytosine

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; DNA FRAGMENT; GENOMIC DNA;

BIOINFORMATICS; CARCINOGENESIS; CELL DIVISION; CELL FUNCTION; DNA METHYLATION; DNA MODIFICATION; EMBRYO DEVELOPMENT; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; CYTOSINE; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASMS; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84889646827     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.69     Document Type: Review

References (155)

1. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev. 23(7), 781-783 (2009
2. Bird A. Perceptions of epigenetics. Nature 447(7143), 396-398 (2007
3. Wongtawan T, Taylor JE, Lawson KA, Wilmut I, Pennings S. Histone H4K20me3 and HP1alpha are late heterochromatin markers in development, but present in undifferentiated embryonic stem cells. J. Cell. Sci. 124(Pt 11), 1878-1890 (2011
4. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447(7143), 425-432 (2007
5. Hajkova P, Jeffries SJ, Lee C, Miller N, Jackson SP, Surani MA. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 329(5987), 78-82 (2010
6. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer 13(7), 497-510 (2013
7. Hansen KD, Timp W, Bravo HC et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43(8), 768-775 (2011
8. Sproul D, Meehan RR. Genomic insights into cancer-Associated aberrant CpG island hypermethylation. Brief Funct. Genomics 12(3), 174-190 (2013
9. Sproul D, Kitchen RR, Nestor CE et al. Tissue of origin determines cancer-Associated CpG island promoter hypermethylation patterns. Genome Biol. 13(10), R84 (2012
10. Reddington JP, Perricone SM, Nestor CE et al. Redistribution of H3K27me3 upon DNA hypomethylation results in derepression of Polycomb target genes. Genome Biol. 14(3), R25 (2013) (Epub ahead of print
11. Cedar H, Bergman Y. Programming of DNA methylation patterns. Annu. Rev. Biochem. 81, 97-117 (2012
12. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3), 247-257 (1999
13. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6), 915-926 (1992
14. Ashe A, Morgan DK, Whitelaw NC et al. A genome-wide screen for modifiers of transgene variegation identifies genes with critical roles in development. Genome Biol. 9(12), R182 (2008
15. Reddington JP, Pennings S, Meehan RR. Non-canonical functions of the DNA methylome in gene regulation. Biochem. J. 451(1), 13-23 (2013
16. Dunican DS, Ruzov A, Hackett JA, Meehan RR. xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function. Development 135(7), 1295-1302 (2008
17. Hervouet E, Vallette FM, Cartron PF. Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 4(7), 487-499 (2009
18. Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet. Cell Genet. 14(1), 9-25 (1975
19. Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-Terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203(4), 971-983 (1988
20. Ooi SK, Bestor TH. The colorful history of active DNA demethylation. Cell 133(7), 1145-1148 (2008
21. Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930-935 (2009
22. Koh KP, Rao A. DNA methylation and methylcytosine oxidation in cell fate decisions. Curr. Opin. Cell. Biol. 25(2), 152-161 (2013
23. Shen L, Zhang Y. 5-Hydroxymethylcytosine: Generation, fate, and genomic distribution. Curr. Opin. Cell. Biol. 25(3), 289-296 (2013
24. Wyatt GR, Cohen SS. A new pyrimidine base from bacteriophage nucleic acids. Nature 170(4338), 1072-1073 (1952
25. Penn NW, Suwalski R, O'Riley C, Bojanowski K, Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem. J. 126(4), 781-790 (1972
26. Kothari RM, Shankar V. 5-methylcytosine content in the vertebrate deoxyribonucleic acids: Species specificity. J. Mol. Evol. 7(4), 325-329 (1976
27. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929), 929-930 (2009
28. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS ONE 5(1), e8888 (2010
29. Nestor C, Ruzov A, Meehan R, Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48(4), 317-319 (2010
30. Munzel M, Globisch D, Carell T. 5-hydroxymethylcytosine, the sixth base of the genome. Angew. Chem. Int. Ed. Engl. 50(29), 6460-6468 (2011
31. Clark SJ, Statham A, Stirzaker C, Molloy PL, Frommer M. DNA methylation: Bisulphite modification and analysis. Nat. Protoc. 1(5), 2353-2364 (2006
32. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22(15), 2990-2997 (1994
33. Eads CA, Danenberg KD, Kawakami K et al. MethyLight: A high-Throughput assay to measure DNA methylation. Nucleic Acids Res. 28(8), e32 (2000
34. Pastor WA, Pape UJ, Huang Y et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473(7347), 394-397 (2011
35. Weber M, Davies JJ, Wittig D et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37(8), 853-862 (2005
36. Weber M, Hellmann I, Stadler MB et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39(4), 457-466 (2007
37. Ficz G, Branco MR, Seisenberger S et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473(7347), 398-402 (2011
38. Huang Y, Pastor WA, Zepeda-Martinez JA, Rao A. The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc. 7(10), 1897-1908 (2012
39. Song CX, Szulwach KE, Fu Y et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29(1), 68-72 (2011
40. Kinney SM, Chin HG, Vaisvila R et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J. Biol. Chem. 286(28), 24685-24693 (2011
41. Nestor CE, Ottaviano R, Reddington J et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 22(3), 467-477 (2012
42. Booth MJ, Branco MR, Ficz G et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336(6083), 934-937 (2012
43. Yu M, Hon GC, Szulwach KE et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149(6), 1368-1380 (2012
44. Borst P, Sabatini R. Base J: Discovery, biosynthesis, and possible functions. Annu. Rev. Microbiol. 62, 235-251 (2008
45. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell selfrenewal and inner cell mass specification. Nature 466(7310), 1129-1133 (2010
46. Freudenberg JM, Ghosh S, Lackford BL et al. Acute depletion of Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling and results in loss of embryonic stem cell identity. Nucleic Acids Res. 40(8), 3364-3377 (2012
47. Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 25(23), 2436-2452 (2011
48. Guo JU, Su Y, Zhong C, Ming GL, Song H. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond. Cell Cycle 10(16), 2662-2668 (2011
49. Zhang J, Gao Q, Li P et al. S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance. Cell Res. 21(12), 1723-1739 (2011
50. Sharif J, Muto M, Takebayashi S et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450(7171), 908-912 (2007
51. Hashimoto H, Horton JR, Zhang X, Bostick M, Jacobsen SE, Cheng X. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455(7214), 826-829 (2008
52. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67(3), 946-950 (2007
53. Hashimoto H, Liu Y, Upadhyay AK et al. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 40(11), 4841-4849 (2012
54. Inoue A, Zhang Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334(6053), 194 (2011
55. Frauer C, Hoffmann T, Bultmann S et al. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS ONE 6(6), e21306 (2011
56. Oda M, Oxley D, Dean W, Reik W. Regulation of lineage specific DNA hypomethylation in mouse trophectoderm. PLoS ONE 8(6), e68846 (2013
57. He YF, Li BZ, Li Z et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333(6047), 1303-1307 (2011
58. Ito S, Shen L, Dai Q et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047), 1300-1303 (2011
59. Schiesser S, Hackner B, Pfaffeneder T et al. Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed. Engl. 51(26), 6516-6520 (2012
60. Smiley JA, Kundracik M, Landfried DA, Barnes VR Sr, Axhemi AA. Genes of the thymidine salvage pathway: Thymine-7-hydroxylase from a Rhodotorula glutinis cDNA library and iso-orotate decarboxylase from Neurospora crassa. Biochim. Biophys. Acta 1723(1-3), 256-264 (2005
61. Rusmintratip V, Sowers LC. An unexpectedly high excision capacity for mispaired 5-hydroxymethyluracil in human cell extracts. Proc. Natl Acad. Sci. USA 97(26), 14183-14187 (2000
62. Cortellino S, Xu J, Sannai M et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146(1), 67-79 (2011
63. Hashimoto H, Hong S, Bhagwat AS, Zhang X, Cheng X. Excision of 5-hydroxymethyluracil and 5-carboxylcytosine by the thymine DNA glycosylase domain: Its structural basis and implications for active DNA demethylation. Nucleic Acids Res. 40(20), 10203-10214 (2012
64. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem. 279(50), 52353-52360 (2004
65. Popp C, Dean W, Feng S et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463(7284), 1101-1105 (2010
66. Nabel CS, Jia H, Ye Y et al. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nat. Chem. Biol. 8(9), 751-758 (2012
67. Gong Z, Zhu JK. Active DNA demethylation by oxidation and repair. Cell Res. 21(12), 1649-1651 (2011
68. Raiber EA, Beraldi D, Ficz G et al. Genomewide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol. 13(8), R69 (2012
69. Zhang L, Lu X, Lu J et al. Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA. Nat. Chem. Biol. 8(4), 328-330 (2012
70. Shen L, Wu H, Diep D et al. Genome-wide analysis reveals TET-And TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153(3), 692-706 (2013
71. Song CX, Szulwach KE, Dai Q et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153(3), 678-691 (2013
72. Inoue A, Shen L, Dai Q, He C, Zhang Y. Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development. Cell Res. 21(12), 1670-1676 (2011
73. Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 38(11), e125 (2010
74. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32(14), 4100-4108 (2004
75. Yildirim O, Li R, Hung JH et al. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147(7), 1498-1510 (2011
76. Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151(7), 1417-1430 (2012
77. Spruijt CG, Gnerlich F, Smits AH et al. Dynamic readers for 5-(hydroxy) methylcytosine and its oxidized derivatives. Cell 152(5), 1146-1159 (2013
78. Meehan RR, Pennings S, Stancheva I. Lashings of DNA methylation, forkfuls of chromatin remodeling. Genes Dev. 15(24), 3231-3236 (2001
79. Dennis K, Fan T, Geiman T, Yan Q, Muegge K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 15(22), 2940-2944 (2001
80. Jin SG, Wu X, Li AX, Pfeifer GP. Genomic mapping of 5- hydroxymethylcytosine in the human brain. Nucleic Acids Res. 39(12), 5015-5024 (2011
81. Williams K, Christensen J, Pedersen MT et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473(7347), 343-348 (2011
82. Szulwach KE, Li X, Li Y et al. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet. 7(6), e1002154 (2011
83. Shi FT, Kim H, Lu W et al. Ten-eleven translocation 1 (tet1) is regulated by O-linked N-Acetylglucosamine transferase (OGT) for target gene repression in mouse embryonic stem cells. J. Biol. Chem. 288(29), 20776-20784 (2013
84. Deplus R, Delatte B, Schwinn MK et al. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS. EMBO J. 32(5), 645-655 (2013
85. Vella P, Scelfo A, Jammula S et al. Tet proteins connect the O-linked N-Acetylglucosamine transferase OGT to chromatin in embryonic stem cells. Mol. Cell 49(4), 645-656 (2013
86. Chen Q, Chen Y, Bian C, Fujiki R, Yu X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493(7433), 561-564 (2013
87. Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 5-hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 12(6), R54 (2011
88. Brodie Of Brodie EB, Nicolay S, Touchon M et al. From DNA sequence analysis to modeling replication in the human genome. Phys. Rev. Lett. 94(24), 248103 (2005
89. Touchon M, Nicolay S, Audit B et al. Replication-Associated strand asymmetries in mammalian genomes: Toward detection of replication origins. Proc. Natl Acad. Sci. USA 102(28), 9836-9841 (2005
90. Huvet M, Nicolay S, Touchon M et al. Human gene organization driven by the coordination of replication and transcription. Genome Res. 17(9), 1278-1285 (2007
91. Jin SG, Jiang Y, Qiu R et al. 5-hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71(24), 7360-7365 (2011
92. Lister R, Mukamel EA, Nery JR et al. Global epigenomic reconfiguration during mammalian brain development. Science 341(6146), 1237905 (2013
93. Thomson JP, Hunter JM, Lempiainen H et al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res. 41(11), 5639-5654 (2013
94. Thomson JP, Lempiainen H, Hackett JA et al. Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol. 13(10), R93 (2012
95. Peraino C, Fry RJ, Staffeldt E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2- Acetylaminofluorene. Cancer Res. 31(10), 1506-1512 (1971
96. Becker FF. Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res. 42(10), 3918-3923 (1982
97. Bachman AN, Phillips JM, Goodman JI. Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol. Sci. 91(2), 393-405 (2006
98. Aydinlik H, Nguyen TD, Moennikes O, Buchmann A, Schwarz M. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of betacatenin-mutated mouse liver tumors. Oncogene 20(53), 7812-7816 (2001
99. Lee GH. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis. Toxicol. Pathol. 28(2), 215-225 (2000
100. Mutoh S, Sobhany M, Moore R et al. Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci. Signal. 6(274), ra31 (2013
101. Lee KW, Pausova Z. Cigarette smoking and DNA methylation. Front. Genet. 4, 132 (2013
102. Haffner MC, Chaux A, Meeker AK et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2(8), 627-637 (2011
103. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 1(2), 239-259 (2009
104. Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell 146(6), 866-872 (2011
105. Iqbal K, Jin SG, Pfeifer GP, Szabo PE. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl Acad. Sci. USA 108(9), 3642-3647 (2011
106. Wossidlo M, Nakamura T, Lepikhov K et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2, 241 (2011
107. Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemiaassociated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 62(14), 4075-4080 (2002
108. Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing Jr. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17(3), 637-641 (2003
109. Hsu CH, Peng KL, Kang ML et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2(3), 568-579 (2012
110. Sun M, Song CX, Huang H et al. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc. Natl Acad. Sci. USA 110(24), 9920-9925 (2013
111. Liu C, Liu L, Chen X et al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS ONE 8(5), e62828 (2013
112. Lian CG, Xu Y, Ceol C et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 150(6), 1135-1146 (2012
113. Bhattacharyya S, Yu Y, Suzuki M et al. Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. Nucleic Acids Res. 41(16), e157 (2013
114. Wood LD, Parsons DW, Jones S et al. The genomic landscapes of human breast and colorectal cancers. Science 318(5853), 1108-1113 (2007
115. Sjoblom T, Jones S, Wood LD et al. The consensus coding sequences of human breast and colorectal cancers. Science 314(5797), 268-274 (2006
116. Kan Z, Jaiswal BS, Stinson J et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466(7308), 869-873 (2010
117. Berger MF, Lawrence MS, Demichelis F et al. The genomic complexity of primary human prostate cancer. Nature 470(7333), 214-220 (2011
118. Abdel-Wahab O, Mullally A, Hedvat C et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114(1), 144-147 (2009
119. Delhommeau F, Dupont S, Della Valle V et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360(22), 2289-2301 (2009
120. Jankowska AM, Szpurka H, Tiu RV et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/ myeloproliferative neoplasms. Blood 113(25), 6403-6410 (2009
121. Kohlmann A, Grossmann V, Klein HU et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J. Clin. Oncol. 28(24), 3858-3865 (2010
122. Langemeijer SM, Kuiper RP, Berends M et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 41(7), 838-842 (2009
123. Tefferi A, Lim KH, Abdel-Wahab O et al. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 23(7), 1343-1345 (2009
124. Quivoron C, Couronne L, Della Valle V et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20(1), 25-38 (2011
125. Koh KP, Yabuuchi A, Rao S et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8(2), 200-213 (2011
126. Ko M, Bandukwala HS, An J et al. Ten-eleventranslocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl Acad. Sci. USA 108(35), 14566-14571 (2011
127. Li Z, Cai X, Cai CL et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118(17), 4509-4518 (2011
128. Moran-Crusio K, Reavie L, Shih A et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20(1), 11-24 (2011
129. Reitman ZJ, Jin G, Karoly ED et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc. Natl Acad. Sci. USA 108(8), 3270-3275 (2011
130. Xu W, Yang H, Liu Y et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1), 17-30 (2011
131. Dang L, White DW, Gross S et al. Cancerassociated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274), 739-744 (2009
132. Ward PS, Patel J, Wise DR et al. The common feature of leukemia-Associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3), 225-234 (2010
133. Chowdhury R, Yeoh KK, Tian YM et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12(5), 463-469 (2011
134. Koivunen P, Lee S, Duncan CG et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390), 484-488 (2012
135. Losman JA, Looper RE, Koivunen P et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339(6127), 1621-1625 (2013
136. Abdel-Wahab O, Manshouri T, Patel J et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res. 70(2), 447-452 (2010
137. Parsons DW, Jones S, Zhang X et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897), 1807-1812 (2008
138. Yan H, Parsons DW, Jin G et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360(8), 765-773 (2009
139. Kang MR, Kim MS, Oh JE et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125(2), 353-355 (2009
140. Murugan AK, Bojdani E, Xing M. Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer. Biochem. Biophys. Res. Commun. 393(3), 555-559 (2010
141. Wang P, Dong Q, Zhang C et al. Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene 32(25), 3091-3100 (2013
142. Noushmehr H, Weisenberger DJ, Diefes K et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17(5), 510-522 (2010
143. Kraus TF, Globisch D, Wagner M et al. Low values of 5- hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors. Int. J. Cancer 131(7), 1577-1590 (2012
144. Muller T, Gessi M, Waha A et al. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-Type gliomas. Am. J. Pathol. 181(2), 675-683 (2012
145. Orr BA, Haffner MC, Nelson WG, Yegnasubramanian S, Eberhart CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS ONE 7(7), e41036 (2012
146. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294(5545), 1337-1340 (2001
147. Tsukada Y, Fang J, Erdjument-Bromage H et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439(7078), 811-816 (2006
148. Baysal BE, Ferrell RE, Willett-Brozick JE et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287(5454), 848-851 (2000
149. Hao HX, Khalimonchuk O, Schraders M et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325(5944), 1139-1142 (2009
150. Bayley JP, Kunst HP, Cascon A et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 11(4), 366-372 (2010
151. Tomlinson IP, Alam NA, Rowan AJ et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat. Genet. 30(4), 406-410 (2002
152. Letouze E, Martinelli C, Loriot C et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23(6), 739-752 (2013
153. Xiao M, Yang H, Xu W et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26(12), 1326-1338 (2012
154. Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366(10), 883-892 (2012
155. Thirlwell C, Eymard M, Feber A et al. Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods 52(3), 248-254 (2010